Topic

longevity-science

3 articles on longevity-science in longevity medicine. View all news →

Sex-specific longitudinal reversal of aging in old frail mice

Oxytocin plus ALK5 Inhibition in Old Mice: What 73% Means

A late-life oxytocin and ALK5-inhibitor experiment extended remaining survival in male mice, but not females. Here is what the 73% result does and does not mean.

oxytocin TGF-beta aging-research
Nature Aging: Emerging strategies, applications and challenges of targeting NAD+ in the clinic

NAD+ and Alzheimer's in 2026: What Human Evidence Actually Shows

NAD+ biology is relevant to brain aging research, but no human trial has shown that NAD+ therapy prevents, slows, or reverses Alzheimer's or Parkinson's disease.

NAD-therapy Alzheimer-disease neurodegenerative-disease
Nature Medicine: Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women

Senolytics in 2026: Human Evidence, Failed Endpoints, and Clinic Safety Questions

A buyer-focused review of senolytics in 2026: what human trials actually found, why dasatinib plus quercetin is not routine anti-aging care, and what to verify before considering a clinic protocol.

senolytics cellular-senescence anti-aging-treatments